Full history for every metric is available with a Kvantra account
Emplicure AB (publ) (EMPLI.ST)
Key financial summary
Financials in SEK| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|---|
| Total revenue | SEK m | - | - | 0 | 0 | 0 | 1 |
| Operating profit | SEK m | -30 | |||||
| Net profit | SEK m | - | - | -5 | -5 | -20 | -29 |
| EPS reported | SEK | -1.20 | |||||
| Operating cashflow per share | SEK | -1.17 | |||||
| Capex per share | SEK | 0.08 | |||||
| FCF per share | SEK | -1.25 | |||||
| Free cash flow | SEK m | -30 | |||||
| Net debt | SEK m | -13 | |||||
| Book value equity | SEK m | 13 | |||||
| Book value per share | SEK | 0.55 | |||||
| Number of shares | m | 24.2 | |||||
| DPS (TTM paid) | SEK | 0.00 |
Financial summary
Financials in SEK| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|---|
| Value | |||||||
| P/E TTM | x | - | |||||
| P/B LTM | x | 1.70 | |||||
| P/S LTM | x | 20.27 | |||||
| P/FCF LTM | x | -0.75 | |||||
| EV/EBITDA LTM | x | -0.33 | |||||
| EV/Sales LTM | x | 8.55 | |||||
| Earnings Yield LTM | % | -128.13% | |||||
| FCF Yield | % | -133.30% | |||||
| Quality | |||||||
| ROE | % | -218.23% | |||||
| ROIC | % | -218.07% | |||||
| Operating margin | % | -2662.0% | |||||
| Gross margin | % | -442.87% | |||||
| FCF/Sales | % | -2702.2% | |||||
| Growth and momentum | |||||||
| EPS Growth YoY | % | - | |||||
| Sales Growth YoY | % | +1302.5% | |||||
| Net Income Growth YoY | % | - | |||||
| FCF Growth | % | - | |||||
| Operating Profit Growth | % | - | |||||
| Dividend and capital structure | |||||||
| Dividend Yield | % | 0.00% | |||||
| Dividend Growth | % | 0.00% | |||||
| Payout Ratio | % | 0.00% | |||||
| FCF/Debt | x | - | |||||
| Net Debt/EBITDA | x | 0.45 | |||||
| EBIT/Net interest | x | -99.89 | |||||
| Net debt/market cap | % | -57.82% | |||||
| Net debt/Equity | x | -0.98 | |||||
| Gross debt/equity | x | 0.00 | |||||
Company overview
Emplicure AB (publ) is a Swedish pharmaceutical firm specializing in the development and research of medicinal products, with a primary focus on managing chronic pain. Their current product offerings feature Empli03, an oral buccal tablet, and Amp01, which are oral nicotine pouches. The company was founded in 2014 and operates from its headquarters in Uppsala, Sweden.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Emplicure AB (publ) (EMPLI.ST)
Emplicure AB (publ) is a Swedish pharmaceutical firm specializing in the development and research of medicinal products, with a primary focus on managing chronic pain. Their current product offerings feature Empli03, an oral buccal tablet, and Amp01, which are oral nicotine pouches. The company was founded in 2014 and operates from its headquarters in Uppsala, Sweden.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free